Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan

Jul 31, 2019

|

NEW YORK – Parsippany, New Jersey-based Interpace Diagnostics announced today that it has signed a contract with Blue Cross Blue Shield of Michigan to cover its ThyGeNext and ThyraMir thyroid cancer detection assays as an in-network service, limiting the insurer's members' out-of-pocket expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan

To read the full story....

Breaking News

Biden Administration Funds $1B for COVID-19 Testing in Indian Country

Scope Fluidics Gets CE Mark for Rapid MRSA MDx Panel

NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test

In Brief This Week: Exact Sciences, Siemens Healthineers, Seegene, Agilent Technologies, and More

Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

What's Popular?

4D Path Prepping FDA Submission for AI-Enabled Breast Cancer Digital Pathology Product

Grail Cancer Early Detection Test Performance Holds Steady as Q2 Launch Approaches

Cancer Dx Firm C2i Genomics Raises $100M in Financing

Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire

OncoDiag Taking Aim at Broader Adoption of Molecular Multiplex Test for Bladder Cancer Recurrence

Sponsorships